Sara Tolaney, MD from Dana Farber Cancer Institute speaks about the SABCS 2021 Presentation – Heterogeneity in treatment outcomes for HER2+ breast cancer – clinical management strategies.
Sara Tolaney, MD @stolaney1 @DanaFarber #SABCS21 #BreastCancer #Cancer #Research Heterogeneity In Treatment Outcomes
